BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15015227)

  • 1. [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
    Husa P; Smejkal P; Husová L; Chalupa P; Penka M
    Vnitr Lek; 2004 Jan; 50(1):30-5. PubMed ID: 15015227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
    Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
    Santagostino E; De Filippi F; Rumi MG; Rivi M; Colombo M; Mannucci PM;
    Transfusion; 2004 May; 44(5):790-4. PubMed ID: 15104664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; Makris M
    Haemophilia; 2006 Sep; 12(5):473-8. PubMed ID: 16919076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C in hemophiliacs.
    Franchini M; Nicolini N; Capra F
    Am J Hematol; 2006 Sep; 81(9):696-702. PubMed ID: 16838339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
    Iino S
    Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].
    Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerborg A; Uhnoo I; Weiland O
    Lakartidningen; 1999 Nov; 96(44):4795-8, 4800. PubMed ID: 10584541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognosis of chronic hepatitis C with regard to the aim of treatment].
    Sodeyama T; Kiyosawa K
    Rinsho Byori; 2001 Aug; 49(8):755-62. PubMed ID: 11573282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus infection in patients with hemophilia].
    Baptista González HA
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S75-9. PubMed ID: 12712860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural human IFNβ and ribavirin combination therapy].
    Joshita S; Tanaka E
    Nihon Rinsho; 2015 Feb; 73(2):273-9. PubMed ID: 25764682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual benefit from intramuscular interferon-beta treatment in a patient with multiple sclerosis and chronic hepatitis-C virus infection.
    Tan FU; Cetinkaya H; Erden E; Ulkatan S; Aydin N
    Hepatogastroenterology; 2002; 49(48):1686-7. PubMed ID: 12397766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis C patients complicated with the other disease].
    Kawabe T; Toda G
    Nihon Rinsho; 2001 Jul; 59(7):1277-83. PubMed ID: 11494537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.